The Organising Committee of the Seventh ESWI Influenza Conference is very excited to launch the Virtual edition of #ESWI2020.

We feel it is has never been more important to connect and come together with influenza, RSV disease, COVID-19 experts and policy makers. COVID-19 has clearly shown that a previously unknown pathogen may strike at any time, in any place and without any warning. There is a clear need for countries to have the capacity to maintain effective alert and response systems to detect and quickly react to outbreaks and to share information about such outbreaks rapidly and transparently.

Read more


abstract topics
EXTRA SESSIONS on the 2019 Novel Coronavirus

The SARS-CoV-2 / COVID-19 track is specifically calling for abstracts with an emphasis on

  • pathogenesis and clinical manifestations
  • virology and epidemiology
  • intervention strategies
  • clinical and outbreak management
  • lessons learned from COVID-19 for the next flu pandemic


Submit your abstract
Access keys are now available !

The access key give access to all sessions, including satellite symposia and keynotes. Building on the success of previous ESWI meetings, #ESWI2020 will feature a wide range of sessions and learning opportunities, showcasing the latest research and developments in the influenza, RSV disease and COVID-19 field.

Join us, get your access key

The seventh ESWI Influenza Conference is hosted by

Young Scientist Fund

Since some of the best and most innovative ideas come from young scientists, ESWI continues to actively encourage the careers of young researchers.

Through the Young Scientist Fund, ESWI provides grants to young scientists, thus contributing to Europe’s continued leading scientific base in influenza and RSV research.

Wednesday 9 December 2020 will open with a plenary session entirely devoted to the work of promising scientists. In past editions, these plenaries were highly appreciated in the influenza community, mainly due to their innovative and refreshing nature.

With the support of:


Read more
Six benefits of our #ESWI2020 virtual edition

1. Increased reach

Extension of your own personal reach to audiences globally. We are building a VIRTUAL SCIENTIFIC KNOWLEDGE CENTER ON INFLUENZA, RSV DISEASE AND COVID-19 that stays on line till January 2021. The organisers will promote the virtual Platform and content by sending out monthly e-newsletters – highlighting specific research and / or topics.

2. More interaction

Research shows that a virtual conference will generate far more interaction with an online audience than in a traditional setting. Visitors will be able to participate during sessions with posts or chats and connect 1-to-1 with speakers before, during and after the session or event.

3. Knowledge transfer

More time and extended availability of research data increases knowledge transfer. Online events on a specific topic are a very compact and clear source of information, driving your scientific work to the next level.

4. Limited travel

On average conference visitors will spend 1 to 3 days traveling from and to event locations. We save some time by making our Conference available on line.

5. Flexibility

You can join from wherever in the world at your own pace, with access whenever you want. You develop your own conference experience.

6. Sustainable

It is almost a no brainer. The reduction of the entire carbon footprint when staff and visitors do not have to travel to a venue is huge!

Why should influenza and RSV experts meet?

1. From a clinical perspective

  • Influenza and RSV cause very similar respiratory disease
  • Influenza and RSV hit the extremes of age the hardest (children and the elderly)

2. From a pathogenesis perspective

  • Clear overlaps as well as clear differences
  • Resulting in major implications for intervention strategies

3. From an intervention strategies perspective (vaccines, antivirals and biological response modifiers)

  • Intervention strategies for influenza are improving and emerging
  • New intervention strategies for RSV are emerging
  • Prospects for:
  • Combined diagnostics/hospital management strategies
  • Combined vaccination strategies
  • Biological response modifiers: similar pathogeneses resulting in similar approaches

4. From a policy perspective

  • Reimbursement policies for both influenza and RSV intervention strategies are crucial


Outcome of the stakeholders conference:


Eswi's partner organizations